Laboratory and Field Evaluation of the Crystal VC-O1 Cholera Rapid Diagnostic Test.
Adolescent
Adult
Child
Child, Preschool
Cholera
/ diagnosis
Clinical Laboratory Techniques
/ economics
Diarrhea
/ epidemiology
Disease Outbreaks
Feces
/ microbiology
Humans
Infant
Infant, Newborn
Kenya
Predictive Value of Tests
Reagent Kits, Diagnostic
/ standards
Sensitivity and Specificity
Serogroup
Vibrio cholerae O1
/ classification
Young Adult
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
05 04 2021
05 04 2021
Historique:
received:
29
09
2020
accepted:
22
01
2021
pubmed:
6
4
2021
medline:
27
1
2022
entrez:
5
4
2021
Statut:
epublish
Résumé
Cholera is a severe acute, highly transmissible diarrheal disease which affects many low- and middle-income countries. Outbreaks of cholera are confirmed using microbiological culture, and additional cases during the outbreak are generally identified based on clinical case definitions, rather than laboratory confirmation. Many low-resource areas where cholera occurs lack the capacity to perform culture in an expeditious manner. A simple, reliable, and low-cost rapid diagnostic test (RDT) would improve identification of cases allowing rapid response to outbreaks. Several commercial RDTs are available for cholera testing with two lines to detect either serotypes O1 and O139; however, issues with sensitivity and specificity have not been optimal with these bivalent tests. Here, we report an evaluation of a new commercially available cholera dipstick test which detects only serotype O1. In both laboratory and field studies in Kenya, we demonstrate high sensitivity (97.5%), specificity (100%), and positive predictive value (100%) of this new RDT targeting only serogroup O1. This is the first field evaluation for the new Crystal VC-O1 RDT; however, with these high-performance metrics, this RDT could significantly improve cholera outbreak detection and improve surveillance for better understanding of cholera disease burden.
Identifiants
pubmed: 33819171
doi: 10.4269/ajtmh.20-1280
pii: tpmd201280
pmc: PMC8176501
doi:
pii:
Substances chimiques
Reagent Kits, Diagnostic
0
Types de publication
Evaluation Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2017-2023Subventions
Organisme : NIAID NIH HHS
ID : R01 AI123422
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI175214
Pays : United States